AskBio Inc
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-20
ACTIVE TRIALS5
PHASE 3 / 2-30
RECRUITING1
READOUTS ≤12 MONTHS0
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| GenePHIT NCT05598333 |
P2 | Active, not recruiting | Congestive Heart Failure | 150 | 2026-10-31 (-37 mo) |
| PIA NCT07215403 |
P2 | Not yet recruiting | PARKINSON DISEASE (Disorder) | 18 | 2028-04-30 (+4 mo) |
| REGENERATE-PD NCT06285643 |
P2 | Active, not recruiting | Parkinson Disease | 59 | 2028-08-31 (+9 mo) |
| AB-1009 (GAA Gene) NCT07282847 |
P1/2 | Recruiting | Pompe Disease (Late-onset); Pompe Disease Late-Onset | 12 | 2028-09 |
| AB-1003 dose level 1 NCT05230459 |
P1/2 | Active, not recruiting | Limb Girdle Muscular Dystrophy; Limb-Girdle Muscular Dystrophy Type 2 | 9 | 2028-12 |